More on HLNE

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (+7.1% Growth)
- Ratings (8.9 Score)
- Dividends

Upcoming Events

- Earnings (11/3/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Hamilton Lane Incorporated (NQ:HLNE)
Delayed: 82.46 -1.24 (1.48%)
Prev. Close $83.70  
Open$85.50 
52 Wk High$ 
52 Wk Low$ 
Day High$85.50 
Day Low$81.78 
P/E N/A  
EPS$ 
Volume517,804 

Friends, Peers and Foes (?): POW, APO, ASRT, GCMG, PTCT (more...)

Oct 20, 2026 08:48 AM Hamilton Lane Inc. (HLNE) PT Lowered to $171 at Oppenheimer
Oct 20, 2026 08:11 AM FDA approves Cosette's Evoxac oral solution for Sjögren's dry mouth
Oct 20, 2026 08:11 AM Cosette Pharmaceuticals Announces FDA Approval of EVOXAC® (cevimeline HCl) Oral Solution, Marking Cosette’s First New Drug Application (NDA) Approval
Oct 16, 2026 08:42 AM Hamilton Lane Inc. (HLNE) PT Lowered to $118 at Morgan Stanley
Oct 15, 2026 07:01 AM Hamilton Lane names Hartley Rogers as co-CEO alongside Delgado-Moreira
Oct 15, 2026 07:00 AM Hamilton Lane Announces Leadership Evolution: Hartley Rogers Named Co-Chief Executive Officer Alongside Juan Delgado-Moreira
Oct 15, 2026 06:59 AM Form 8-K Hamilton Lane INC For: Oct 12
Oct 13, 2026 09:17 AM Hamilton Lane Inc. (HLNE) PT Lowered to $115 at UBS
Oct 6, 2026 07:00 AM Hamilton Lane Incorporated to Announce Second Quarter Fiscal 2027 Results on November 3, 2026
Oct 1, 2026 04:17 PM Wells Fargo Starts Hamilton Lane Inc. (HLNE) at Overweight
View All Articles

Entities mentioned with HLNE

View All Entities